Page last updated: 2024-08-23
paclitaxel and apcin
paclitaxel has been researched along with apcin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, Z; Hu, G; Huang, F; Huang, P; Le, X; Li, Q; Ma, J; Yang, H; Yang, J | 1 |
| Bai, L; Bhuniya, R; Howie, KL; Li, W; Park, F; Wang, R; Yang, CY; Yuan, X | 1 |
Other Studies
2 other study(ies) available for paclitaxel and apcin
| Article | Year |
|---|---|
Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin.
Topics: Antineoplastic Agents; Apoptosis; Carbamates; Cdc20 Proteins; Cell Movement; Cell Proliferation; Diamines; Drug Discovery; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Microtubules; Mitosis; Molecular Structure; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance; Tubulin Modulators | 2020 |
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors.
Topics: | 2022 |